<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-05T18:29:29Z</responseDate><request verb="GetRecord" identifier="oai:uvadoc.uva.es:10324/45068" metadataPrefix="didl">https://uvadoc.uva.es/oai/request</request><GetRecord><record><header><identifier>oai:uvadoc.uva.es:10324/45068</identifier><datestamp>2021-06-24T07:16:56Z</datestamp><setSpec>com_10324_44585</setSpec><setSpec>com_10324_954</setSpec><setSpec>com_10324_894</setSpec><setSpec>col_10324_44586</setSpec></header><metadata><d:DIDL xmlns:d="urn:mpeg:mpeg21:2002:02-DIDL-NS" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd">
<d:DIDLInfo>
<dcterms:created xmlns:dcterms="http://purl.org/dc/terms/" xsi:schemaLocation="http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/dcterms.xsd">2021-01-19T08:53:45Z</dcterms:created>
</d:DIDLInfo>
<d:Item id="hdl_10324_45068">
<d:Descriptor>
<d:Statement mimeType="application/xml; charset=utf-8">
<dii:Identifier xmlns:dii="urn:mpeg:mpeg21:2002:01-DII-NS" xsi:schemaLocation="urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd">urn:hdl:10324/45068</dii:Identifier>
</d:Statement>
</d:Descriptor>
<d:Descriptor>
<d:Statement mimeType="application/xml; charset=utf-8">
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>Nonsteroidal anti-inflammatory drugs inhibit vascular smooth muscle cell proliferation by enabling the Ca2+-dependent inactivation of calcium release-activated calcium/Orai channels normally prevented by mitocondria</dc:title>
<dc:creator>Muñoz Conejero, Eva</dc:creator>
<dc:creator>Valero, Ruth Ana</dc:creator>
<dc:creator>Quintana, Ariel</dc:creator>
<dc:creator>Hoth, Markus</dc:creator>
<dc:creator>Núñez Llorente, Lucía</dc:creator>
<dc:creator>Villalobos Jorge, Carlos</dc:creator>
<dc:description>Producción Científica</dc:description>
<dc:description>Abnormal vascular smooth muscle cell (VSMC) proliferation contributes to occlusive and proliferative disorders of the vessel wall. Salicylate and other nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit VSMC proliferation by an unknown mechanism unrelated to anti-inflammatory activity. In search for this mechanism, we have studied the effects of salicylate and other NSAIDs on subcellular Ca2+ homeostasis and Ca2+-dependent cell proliferation in rat aortic A10 cells, a model of neointimal VSMCs. We found that A10 cells displayed both store-operated Ca2+ entry (SOCE) and voltage-operated Ca2+ entry (VOCE), the former being more important quantitatively than the latter. Inhibition of SOCE by specific Ca2+ released-activated Ca2+ (CRAC/Orai) channels antagonists prevented A10 cell proliferation. Salicylate and other NSAIDs, including ibuprofen, indomethacin, and sulindac, inhibited SOCE and thereby Ca2+-dependent, A10 cell proliferation. SOCE, but not VOCE, induced mitochondrial Ca2+ uptake in A10 cells, and mitochondrial depolarization prevented SOCE, thus suggesting that mitochondrial Ca2+ uptake controls SOCE (but not VOCE) in A10 cells. NSAIDs depolarized mitochondria and prevented mitochondrial Ca2+ uptake, suggesting that they favor the Ca2+-dependent inactivation of CRAC/Orai channels. NSAIDs also inhibited SOCE in rat basophilic leukemia cells where mitochondrial control of CRAC/Orai is well established. NSAIDs accelerate slow inactivation of CRAC currents in rat basophilic leukemia cells under weak Ca2+ buffering conditions but not in strong Ca2+ buffer, thus excluding that NSAIDs inhibit SOCE directly. Taken together, our results indicate that NSAIDs inhibit VSMC proliferation by facilitating the Ca2+-dependent inactivation of CRAC/Orai channels which normally is prevented by mitochondria clearing of entering Ca2+.</dc:description>
<dc:date>2021-01-19T08:53:45Z</dc:date>
<dc:date>2021-01-19T08:53:45Z</dc:date>
<dc:date>2011</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:identifier>Journal of Biological Chemistry, 2011, vol. 286, n. 18. p. 16186-16196</dc:identifier>
<dc:identifier>0021-9258</dc:identifier>
<dc:identifier>http://uvadoc.uva.es/handle/10324/45068</dc:identifier>
<dc:identifier>10.1074/jbc.M110.198952</dc:identifier>
<dc:language>eng</dc:language>
<dc:relation>https://www.sciencedirect.com/science/article/pii/S0021925820514361?via%3Dihub</dc:relation>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:rights>http://creativecommons.org/licenses/by-nc-nd/3.0/</dc:rights>
<dc:rights>© 2011 Elsevier</dc:rights>
<dc:rights>Attribution-NonCommercial-NoDerivs 3.0 Unported</dc:rights>
<dc:publisher>Elsevier</dc:publisher>
</oai_dc:dc>
</d:Statement>
</d:Descriptor>
<d:Component id="10324_45068_1">
<d:Resource ref="https://uvadoc.uva.es/bitstream/10324/45068/1/Nonsteroidal-anti-inflammatory-drugs.pdf" mimeType="application/pdf"/>
</d:Component>
</d:Item>
</d:DIDL></metadata></record></GetRecord></OAI-PMH>